Listed

Nutex Health Inc.: Form 10-K/A for the period ended Dec 31, 2018

Filed with the SEC on Apr 17, 2019 and accepted by EDGAR at Apr 17, 2019, 14:09 ET.

Share

Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2018-01-01 to 2018-12-31$60.2kus-gaap:Revenues
Cost of revenue12 months2018-01-01 to 2018-12-31$31.1kus-gaap:CostOfRevenue
Gross profit12 months2018-01-01 to 2018-12-31$29.1kus-gaap:GrossProfit
Operating income12 months2018-01-01 to 2018-12-31−$1.8mus-gaap:OperatingIncomeLoss
Interest expense12 months2018-01-01 to 2018-12-31$642.1kus-gaap:InterestExpense
Net income12 months2018-01-01 to 2018-12-31−$2.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2018-01-01 to 2018-12-31−$0.02us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-01-01 to 2018-12-31−$765.5kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2018-12-31$369us-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$42.3kus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$2.6mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$1.4mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2018-12-31$1.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001607062-19-000163. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.